Climb Bio News

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Dec 20 16:22 ET

Climb Bio | EFFECT: Others

Nov 25 06:17 ET

Climb Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(3.23%),Deep Track Biotechnology Master Fund, Ltd.(3.23%), etc.

Nov 14 09:31 ET

Climb Bio | 4: Statement of changes in beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 12 17:52 ET

Climb Bio | 3: Initial statement of beneficial ownership of securities-Director WILLIAMS DOUGLAS E

Nov 12 17:38 ET

Climb Bio | S-3: Registration statement for specified transactions by certain issuers

Nov 12 16:55 ET

Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12 16:42 ET

Climb Bio | 10-Q: Q3 2024 Earnings Report

Nov 12 16:03 ET

8-K: Current report

Oct 15 07:09 ET

Eliem Therapeutics | 8-K: Current report

Oct 2 16:20 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Sep 20 21:57 ET

Eliem Therapeutics | 8-K: Current report

Aug 27 17:25 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kaplan Brett

Aug 26 17:51 ET

Eliem Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Kaplan Brett

Aug 26 17:41 ET

Eliem Therapeutics | 8-K: Current report

Aug 26 07:11 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Aug 16 16:28 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.70%),Affinity Asset Advisors, LLC (EIN(2.70%)

Aug 14 16:12 ET

Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Second Quarter Financial Results

Aug 14 06:16 ET

Eliem Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 06:11 ET

Eliem Therapeutics | EFFECT: Others

Jul 24 06:05 ET